Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Yu L; Liebenberg K; Shen Y; Liu F; Xu Z; Wu L; Hao X; Zhang W; Chan HL; Wei B; Lorenzi P; Gao Y; Bado I; Dominguez LB; Rivas CH; Aguirre S; Pingel B; Wu Y-H; Ding L; Liu J; Edwards DG, Eberlin LS; Xiang H.-F. Zhang. (Mar 28, 2025) Immunity 58 (1-17). [PubMed]